1. |
Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol, 2009, 15(34): 4240-4262.
|
2. |
Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology, 2008, 48(1): 308-321.
|
3. |
Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol, 2014, 40(5): 489-495.
|
4. |
de Santibanes E, Ardiles V, Alvarez FA,et al. Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy. HPB (Oxford), 2012, 14(1): 67-70.
|
5. |
Peng C, Li C, Wen T,et al. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study. Int J Surg, 2016, 32: 167-173.
|
6. |
Higgins ES, Banks WL Jr. Cognate effects of ethanol, hydrazine and tissue regeneration on heaptic mitochondrial activities. Biochem Pharmacol, 1971, 20(7): 1513-1524.
|
7. |
Noji T, Tsuchikawa T, Okamura K,et al. Resection and reconstruction of the hepatic artery for advanced perihilar cholangiocarcinoma: result of arterioportal shunting. J Gastrointest Surg, 2015, 19(4): 675-681.
|
8. |
Shimizu H, Hosokawa I, Ohtsuka M,et al. Clinical significance of anatomical variant of the left hepatic artery for perihilar cholangiocarcinoma applied to right-sided hepatectomy. World J Surg, 2014, 38(12): 3210-3214.
|
9. |
Neuhaus P, Jonas S, Bechstein WO,et al. Extended resections for hilar cholangiocarcinoma. Ann Surg, 1999, 230(6): 808-818, discussion 819.
|
10. |
de Jong MC, Marques H, Clary BM,et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer, 2012, 118(19): 4737-4747.
|
11. |
Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg, 1966, 112(3): 337-347.
|
12. |
Michels NA. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer, 1953, 6(4): 708-724.
|
13. |
Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 1966; 112(3): 337-347.
|
14. |
Beaussier M, Wendum D, Fouassier L,et al. Adaptative bile duct proliferative response in experimental bile duct ischemia. J Hepatol, 2005, 42(2): 257-265.
|
15. |
Faleschini G, Vadala di Prampero SF, Bulajic M,et al. Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation. Eur J Gastroenterol Hepatol, 2015, 27(2): 150-154.
|
16. |
Goel A, Mehta N, Guy J,et al. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl 2014, 20(10): 1221-1228.
|
17. |
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972, 26(4): 239-257.
|
18. |
Skov Olsen P, Boesby S, Kirkegaard P,et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology, 1988, 8(5): 992-996.
|
19. |
Margaritis VG, Filos KS, Michalaki MA,et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg, 2005, 29(10): 1329-1334.
|
20. |
Cindoruk M, Kerem M, Karakan T,et al. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterol, 2007, 7: 44.
|
21. |
Sheen-Chen SM, Ho HT, Chia-Pei L,et al. The effect of insulin-like growth factor-I on hepatocyte apoptosis after bile duct ligation in rat. Dig Dis Sci, 2006, 51(12): 2220-2224.
|
22. |
Dirlik M, Karahan A, Canbaz H,et al. Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopoly-saccharide-induced sepsis. Curr Ther Res Clin Exp, 2009, 70(4): 299-315.
|
23. |
Chen G, Wang S, Bie P,et al. Endogenous bile salts are associated with bile duct injury in the rat liver transplantation model. Transplantation, 2009, 87(3): 330-339.
|
24. |
Joseph B, Kapoor S, Schilsky ML,et al. Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology, 2009, 49(5): 1616-1624.
|